The generic-drug maker makes a major push into branded-drug development. Today Teva licensed a preclinical cancer drug candidate, XMT-1107, from privately held Mersana Therapeutics. Teva is on the ...

Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.

Teva’s mega-cost-cutting drive hasn’t been popular with workers or its home country of Israel. Analysts, on the other hand, like what they’ve seen so far from the company’s new executives. These days, ...

Last week, the FTC issued a civil investigative demand, effectively a subpoena, to Teva. This demand compels the company to provide internal communications, analysis, and financial data related to the ...

Not every recent TEVA put player is bearish toward the stock Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been a long-term laggard on the charts, dropping over half its value since topping ...

Every day, Wall Street analysts upgrade some stocks, downgrade others, and "initiate coverage" on a few more. But do these analysts even know what they're talking about? Today, we're taking one ...

TEL AVIV (Reuters) - Teva Pharmaceutical Industries reported a smaller-than-expected drop in second-quarter profit on Wednesday and said its chief financial officer was leaving the company. Despite ...

<0> Teva Pharmaceutical Industries Ltd.IR:United States 215-591-8912or215-591-3033orIsrael 972 (3) 926-7656orPR:Israel 972 (3) 926-7687orUnited States 215-591-8974or215-284-0213 </0> Teva ...